Cargando…

Network meta-analysis combining individual patient and aggregate data from a mixture of study designs with an application to pulmonary arterial hypertension

BACKGROUND: Network meta-analysis (NMA) is a methodology for indirectly comparing, and strengthening direct comparisons of two or more treatments for the management of disease by combining evidence from multiple studies. It is sometimes not possible to perform treatment comparisons as evidence netwo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thom, Howard HZ, Capkun, Gorana, Cerulli, Annamaria, Nixon, Richard M, Howard, Luke S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4403724/ https://www.ncbi.nlm.nih.gov/pubmed/25887646 http://dx.doi.org/10.1186/s12874-015-0007-0

Ejemplares similares

Indirect comparisons of ranibizumab and dexamethasone in macular oedema secondary to retinal vein occlusion
por: Thom, Howard HZ, et al.
Publicado: (2014)

Relationship between FEV(1 )change and patient-reported outcomes in randomised trials of inhaled bronchodilators for stable COPD: a systematic review
por: Westwood, Marie, et al.
Publicado: (2011)

Exertional dyspnoea in pulmonary arterial hypertension
por: Dumitrescu, Daniel, et al.
Publicado: (2017)

Connective tissue disease-associated pulmonary arterial hypertension
por: Condliffe, Robin, et al.
Publicado: (2015)

Pulmonary arterial hypertension: the burden of disease and impact on quality of life
por: Delcroix, Marion, et al.
Publicado: (2015)

Patient engagement and self-management in pulmonary arterial hypertension
por: Graarup, Jytte, et al.
Publicado: (2016)

Management of pulmonary arterial hypertension in patients aged over 65 years
por: Sitbon, Olivier, et al.
Publicado: (2019)

Physicians’ and patients’ expectations of therapies for pulmonary arterial hypertension: where do they meet?
por: Howard, Luke S., et al.
Publicado: (2014)

Comparative efficacy of indacaterol 150 μg and 300 μg versus fixed-dose combinations of formoterol + budesonide or salmeterol + fluticasone for the treatment of chronic obstructive pulmonary disease – a network meta-analysis
por: Cope, Shannon, et al.
Publicado: (2011)

Supplementation of iron in pulmonary hypertension: Rationale and design of a phase II clinical trial in idiopathic pulmonary arterial hypertension
por: Howard, Luke S.G.E., et al.
Publicado: (2013)

Understanding the impact of pulmonary arterial hypertension on patients' and carers' lives
por: Guillevin, Loïc, et al.
Publicado: (2013)

Egg and banana sign of severe pulmonary arterial hypertension
por: Veean, Satyam, et al.
Publicado: (2018)

Efficacy of indacaterol 75 μg versus fixed-dose combinations of formoterol-budesonide or salmeterol-fluticasone for COPD: a network meta-analysis
por: Cope, Shannon, et al.
Publicado: (2012)

Lung Function, Inflammation, and Endothelin‐1 in Congenital Heart Disease–Associated Pulmonary Arterial Hypertension
por: Low, Andrew, et al.
Publicado: (2018)

Wave Intensity Analysis Provides Novel Insights Into Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension
por: Su, Junjing, et al.
Publicado: (2017)

Pulmonary Arterial Hypertension: Combination Therapy in Practice
por: Burks, Marsha, et al.
Publicado: (2018)

Pulmonary Arterial Hypertension Specific Therapy in Patients with Combined Post- and Precapillary Pulmonary Hypertension
por: Alfraidi, Hassan, et al.
Publicado: (2018)

Combination targeted pulmonary hypertension therapy in the resolution of Dasatinib-associated pulmonary arterial hypertension
por: Jose, Arun, et al.
Publicado: (2017)

A trial design to maximize knowledge of the effects of rodatristat ethyl in the treatment of pulmonary arterial hypertension (ELEVATE 2)
por: Lazarus, Howard M., et al.
Publicado: (2022)

Impact of the COVID-19 pandemic on healthcare resource utilization across selected disease areas in the USA
por: Engelbrecht, Kayla, et al.
Publicado: (2022)

Cardiopulmonary exercise testing in a combined screening approach to individuate pulmonary arterial hypertension in systemic sclerosis
por: Santaniello, Alessandro, et al.
Publicado: (2020)

Abnormal platelet aggregation in pediatric pulmonary hypertension
por: Handler, Stephanie S., et al.
Publicado: (2022)

Positioning imatinib for pulmonary arterial hypertension: A phase I/II design comprising dose finding and single-arm efficacy
por: Wilkins, Martin R., et al.
Publicado: (2021)

The evolving landscape of combination therapy for pulmonary arterial hypertension
por: Griffin, Matthew, et al.
Publicado: (2016)

The role of combination therapy in managing pulmonary arterial hypertension
por: Ghofrani, Hossein-Ardeschir, et al.
Publicado: (2014)

Exercise cardiac MRI unmasks right ventricular dysfunction in acute hypoxia and chronic pulmonary arterial hypertension
por: Jaijee, Shareen, et al.
Publicado: (2018)

Reduced plasma levels of small HDL particles transporting fibrinolytic proteins in pulmonary arterial hypertension
por: Harbaum, Lars, et al.
Publicado: (2019)

Selexipag in the treatment of pulmonary arterial hypertension: design, development, and therapy
por: Hardin, Elizabeth Ashley, et al.
Publicado: (2016)

Clinical trial design and new therapies for pulmonary arterial hypertension
por: Sitbon, Olivier, et al.
Publicado: (2019)

Cortisol/cortisone levels and quality of life in individuals with pulmonary arterial hypertension
por: Tulloh, RMR, et al.
Publicado: (2020)

The importance of patient perspectives in pulmonary hypertension
por: McGoon, Michael D., et al.
Publicado: (2019)

Simvastatin, Sildenafil and Their Combination in Monocrotaline Induced Pulmonary Arterial Hypertension
por: Lee, Dong Seok, et al.
Publicado: (2010)

Initial combination therapy of macitentan and tadalafil in pulmonary arterial hypertension
por: Sitbon, Olivier, et al.
Publicado: (2020)

Dapagliflozin, sildenafil and their combination in monocrotaline-induced pulmonary arterial hypertension
por: Tang, Yi, et al.
Publicado: (2022)

Relevance of comorbidities on initial combination therapy in pulmonary arterial hypertension
por: Badagliacca, Roberto, et al.
Publicado: (2022)

Deprivation and prognosis in patients with pulmonary arterial hypertension: missing the effect of deprivation on a rare disease?
por: Sofianopoulou, Eleni, et al.
Publicado: (2020)

Pulmonary arterial hypertension
por: Montani, David, et al.
Publicado: (2013)

Pulmonary Arterial Hypertension
por: Michelakis, Evangelos D., et al.
Publicado: (2007)

Mixture Proportion Design Method of Steel Fiber Reinforced Recycled Coarse Aggregate Concrete
por: Gao, Danying, et al.
Publicado: (2019)

Short-Term Hemodynamic Effects of Apelin in Patients With Pulmonary Arterial Hypertension
por: Brash, Lauren, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_hg58eok1anq98g3os31cdbnknu